AI (artificial intelligence) is rapidly gaining traction in mental health care, and for good reason. It offers the potential to streamline care, uncover clinical insights, and broaden access to ...
MedPage Today on MSN
Gabapentin Under Scrutiny: 2025 Data Challenged Safety Profile
In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated.
This promising outlook positions AI as a powerful tool in addressing global mental health crises. However, a recent report from Spring Health highlights a significant and often overlooked risk for HR ...
Once promoted as a safer alternative to opioids, the widely prescribed drug is now linked to withdrawal, overdoses and serious side effects that many patients say they were never warned about.
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities ...
The hype around the off-label use of the immunosuppressant rapamycin to prevent aging and increase longevity could be unfounded. This is the warning of researchers who have critically explored ...
The US Food and Drug Administration (FDA) held a 2-day public hearing this week to solicit input about the marketing and use of medications and medical devices for off-label use. It is fairly common ...
Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results